mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced  
Phone 01494 818 000
Current Jobs

Sales Specialist
Location: North East

Product Manager
Location: West Yorkshire

Territory Manager - Sports Medicine
Location: M62 Corridor

Regional Business Manager
Location: North East Region

Sales Specialist - PAS
Location: North East

Expert Trainer
Location: Mid UK

Field Sales Coach - Central
Location: Central UK

Senior Brand Manager
Location: Welwyn Garden City

Territory Manager - Sports Medicine
Location: South Central

Sales Specialist - MSS
Location: West Midlands

Centralised Diagnostics Sales Specialist
Location: South and Central London

Medical Advisor
Location: Princes Risborough, Bucks

Training Manager - Renal & Neurology and ELearnin
Location: Maidenhead, Berks

Training Manager - Part-time
Location: Maidenhead

Territory Manager - Sports Medicine
Location: West Scotland

Researchers develop RNA-mapping app for the iPhone

Posted on 02/09/2010 in Scientific Developments/Breakthroughs

Scientists at Stanford University have created a new application for the Apple iPhone which allows them to experimentally capture a global snapshot of thousands of RNA molecules within cells.

The application uses deep-sequencing techniques to create a two-dimensional image of the complex structure of the molecules, without the need for complex and time-consuming analysis.

Conducting tests of the technology using baker's yeast, the researchers were able to identify previously undocumented patterns and common structures in RNA which can affect its functioning.

It is hoped that this technology can be expanded upon to provide analysis of more complex RNA structures from different organisms in future.

Dr Howard Chang, associate professor of dermatology at the university, said: "We can leverage this information for biological insight into how RNA structures may change under different conditions. There are levels of complexity that we're only just beginning to understand."

RNA research is becoming an increasingly prominent area in drug development, with Novartis and Quark agreeing a deal last month to jointly produce a p53 temporary inhibitor siRNA drug for kidney transplant patients.ADNFCR-8000103-ID-800049219-ADNFCR

Other news stories from 02/09/2010

Read more in the Zenopa News Archive

How this news is generated

Morag Shea
Scotland Manager


Pharmaceutical Sales Jobs | Pharmaceutical Executive Jobs | Pharmaceutical Marketing Jobs | Medical Sales Jobs | Medical Devices Marketing Jobs | Medical Executive Jobs
Dental Sales Jobs | Veterinary Sales Jobs | Scientific Sales Jobs | Consumer Healthcare Sales Jobs | Consumer Healthcare Management Jobs | Medical Writing Jobs
Medical Writer Jobs | Healthcare PR Jobs | Animal Health Sales Jobs

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2012 Zenopa Ltd | terms & conditions of use